Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Inventors of GyroGlove announce plans to put the innovative ‘wearable’ into production in the coming year

The company behind GyroGlove has announced plans to bring the tremor-reducing device into production in 2017, following final testing and prototype development.

Founder Faii Ong, said: “We are in the midst of our last round of comprehensive modelling followed by prototyping for manufacture. After months of much grimacing, testing, caffeine and gnashing of teeth, the modelling results confirm all the live testing and data.”

GyroGlove is hi-tech glove that mechanically stabilises hands for people living with Parkinson’s. Further testing will begin in March 2017 and the company is calling for more volunteers to take part in the process.

Image credit: GyroGear

Sign up here to join the GyroCircle test volunteers group

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Patients in video tribute to ‘knockout’ Ali Center

Patients pay tribute to 'knockout' Parkinson's treatment centre

Indian Ocean Row 2018: the story so far

An update on the four men rowing 3,600 miles for Parkinson’s

Fast-acting inhalable levodopa produces positive results in clinical trial

Is inhalable levodopa for treating Parkinson’s one step closer?

Musical therapy study to receive $20 million in funding

The National Institutes of Health (NIH) is donating US $20 million to a medical trial researching the effects of musical therapy on brain conditions, including Parkinson’s. The trial will be carried out by the Sound Health initiative, a joint partnership between the NIH and The John F Kennedy Center for the Performing Arts. The initiative was created to expand current knowledge of how listening, performing and creating music could be harnessed for health and wellness. Francis S. Collins, director of the NIH, said: “We know that the beat of a metronome can steady the gait of someone with Parkinson’s disease, for example, but we don’t fully understand how that happens. “If we can pinpoint in the brain how music therapy works through the use of imaging and biomarkers, the hope is that we can improve its effectiveness and apply it more broadly to improve the lives of millions of people.”

Researchers develop automated system to diagnose Parkinson’s

In an international study, researchers from the US, Germany and Austria have used a non-invasive MRI method to develop an automated system that can diagnose Parkinson’s. As part of the study – published in medical journal ‘The Lancet Digital Health’ – researchers worked with 1,002 patients and used an imaging method that measures how water molecules diffuse in the brain. This helped them to identify where neurodegeneration is occurring. Researchers hope this will help improve the accuracy of early Parkinson’s diagnoses – which they estimate to be around 58%. Dr David Vaillancourt, who led the study, said: “Our method may help to reduce the number of misdiagnosed cases in the future. Since these diseases require unique treatment plans and different medications, and clinical trials testing new medications require the correct diagnosis, getting it right is important for patient care.”

MJFF announces $10 million competition for Parkinson’s

The Michael J Fox Foundation has launched the ‘Ken Griffin Alpha-synuclein Imaging Competition’ – a US $10 million programme aiming to develop a game-changing tool for Parkinson’s research. As part of the competition, participating teams will compete in a scientific race to build a device that is able to identify alpha-synuclein – a protein closely associated with Parkinson’s. Although almost everyone diagnosed with Parkinson’s has clumps of alpha-synuclein in the brain, these are currently only visible when analysing tissue during autopsies. The competition is named after Ken Griffin, CEO of US investment firm Citadel who has given US $7.5 million funding to the programme. Griffin – whose father has Parkinson’s – said: “If we have the imaging capability to observe the pathology that arises from protein-misfolding in real time, and understand how drugs are impacting people in real time, that would be a major advance.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Patients in video tribute to ‘knockout’ Ali Center

Global update

Indian Ocean Row 2018: the story so far

Advances

Fast-acting inhalable levodopa produces positive results in clinical trial

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Patients in video tribute to ‘knockout’ Ali Center

Global update

Indian Ocean Row 2018: the story so far

Advances

Fast-acting inhalable levodopa produces positive results in clinical trial

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Sign in